Muscle Dysfunction in Patients With Haematological Diseases
NCT05150561 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 216
Last updated 2025-08-11
Summary
PURPOSE: To evaluate the prevalence and prognostic value of sarcopenia in patients diagnosed with hematological cancer diseases.
Conditions
- Hematologic Diseases
- Acute Myeloid Leukemia
- Acute Lymphoid Leukemia
- Myelodysplastic Syndromes
- Lymphoma
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-10-01
- Primary Completion
- 2025-10-30
- Completion
- 2026-05-01
Countries
- Denmark
Study Locations
More Related Trials
-
Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy
NCT04014764 ·Status: COMPLETED
-
Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy
NCT01543100 ·Status: COMPLETED ·Phase: NA
-
The Prognostic Value of Serum Biomarkers in Osteosarcoma
NCT05093101 ·Status: COMPLETED
-
Biology and Genetics of Smouldering Myeloma
NCT05047107 ·Status: UNKNOWN
-
Collection of Retrospective (Archival) Samples and Prospective Collection of Surplus Tissue and Blood Samples
NCT02239575 ·Status: WITHDRAWN
-
Pathogenesis of Hematologic Malignancies
NCT01728402 ·Status: ENROLLING_BY_INVITATION
-
Aberrant Expression of CD56 in Patients With Hematologic Malignancies.
NCT04546945 ·Status: RECRUITING
-
The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma
NCT05100368 ·Status: COMPLETED
-
LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia
NCT01999556 ·Status: COMPLETED
-
Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study
NCT00858585 ·Status: COMPLETED
-
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
NCT07019155 ·Status: RECRUITING
-
Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives
NCT01210209 ·Status: COMPLETED
-
Prediction of True Oligo-metastatic Disease.
NCT05806151 ·Status: RECRUITING
-
Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer
NCT03214991 ·Status: UNKNOWN
-
Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
NCT00534820 ·Status: COMPLETED ·Phase: NA
-
Prospective and Retrospective Cohort Study to Find New Prognostic Factors and Therapeutic Targets in Patients With Newly Diagnosed or Relapsed Malignant Hematologic Disorder Excluding Acute Leukemia
NCT02330718 ·Status: UNKNOWN
-
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
NCT01187173 ·Status: COMPLETED
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
NCT01503619 ·Status: COMPLETED
-
Metastatic Leiomyosarcoma Biomarker Protocol
NCT05653388 ·Status: RECRUITING
-
Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies
NCT04298892 ·Status: UNKNOWN
-
Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH
NCT02552381 ·Status: COMPLETED
-
Association Between Multiple Coagulation-related Factors and Lymph Node Metastasis in Patients With Gastric Cancer: A Retrospective Cohort Study
NCT05592925 ·Status: UNKNOWN
-
Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma
NCT03414827 ·Status: RECRUITING
-
Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.
NCT04213664 ·Status: UNKNOWN
-
Analysis of Circulating Tumor Markers in Blood
NCT04025541 ·Status: RECRUITING ·Phase: NA